跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-21
首页
药物
R-21
R-21
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Viral polymerase inhibitors
EP 1891950 A1
申请人: BOEHRINGER INGELHEIM CA LTD
优先权: 2001
CN
EP
US
9 件公开
Energy transfer dyes with enhanced fluorescence
US 7169939 B2
申请人: APPLERA CORP
优先权: 2004
US
9 件公开
N-acylamino benzyl ether derivatives
US 7053245 B2
申请人: HOFFMANN LA ROCHE
优先权: 2002
US
5 件公开
Insulin secretion potentiator
US 2005143464 A1
申请人: USE TECHNO CORP
优先权: 2003
CN
EP
US
4 件公开
Process for the preparation of enantiopure pyrrolidin-2-one derivatives
US 7148362 B2
申请人: HOFFMANN LA ROCHE
优先权: 2003
CN
US
4 件公开
METHOD FOR TREATING THROMBOSIS AND INHIBITING PLATELET AGGREGATION WITH 21-(S)-ARGATROBAN
US 2010016356 A1
申请人: TIANJIN WEIJIE TECHNOLOGY CO L
优先权: 2007
CN
US
4 件公开
Novel physiologically active substances
US 2006009439 A1
申请人: EISAI CO LTD
优先权: 2002
US
4 件公开
ORGANIC COMPOUND FOR ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DIODE INCLUDING SAME
EP 3754737 A1
申请人: SFC CO LTD
优先权: 2019
CN
EP
US
3 件公开
Method for selective preparation of aryl 5-thio-beta-D-aldohexopyranosides
US 7250522 B2
申请人: TAISHO PHARMACEUTICAL CO LTD
优先权: 2002
EP
US
3 件公开
Anti-Inflammatory Agents
US 2008076772 A1
申请人: PHARMA MAR SA
优先权: 2004
CN
US
3 件公开
第 1 / 10 页
上一页
下一页
药物
反馈